Covered recipient · General Payments record
HEATHER M MANOS
Allopathic & Osteopathic Physicians Family Medicine Addiction Medicine
General Payments · PY2018–2024
$1,998.88
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $366.82 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $74.55 | 4 |
| Alkermes, Inc. | $61.42 | 2 |
| Braeburn Inc. | $48.13 | 2 |
| Gilead Sciences, Inc. | $44.81 | 2 |
| Acerta Pharma LLC | $42.29 | 2 |
| Novo Nordisk AS | $35.65 | 2 |
| JAZZ PHARMACEUTICALS INC. | $23.92 | 1 |
| Seqirus USA Inc | $21.20 | 1 |
| Lilly USA, LLC | $14.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $30.64 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120547289 | CMS |
| Alkermes, Inc. | $30.78 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120547291 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.16 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104458334 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.13 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104299914 | CMS |
| Braeburn Inc. | $15.32 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601841 | CMS |
| Braeburn Inc. | $32.81 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601843 | CMS |
| Gilead Sciences, Inc. | $19.54 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133749706 | CMS |
| Gilead Sciences, Inc. | $25.27 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133749708 | CMS |
| Indivior Inc. | $14.87 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532851 | CMS |
| Indivior Inc. | $17.61 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532853 | CMS |
| Indivior Inc. | $18.24 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532855 | CMS |
| Indivior Inc. | $23.83 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532857 | CMS |
| JAZZ PHARMACEUTICALS INC. | $23.92 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150214470 | CMS |
| Lilly USA, LLC | $14.85 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135016082 | CMS |
| Novo Nordisk Inc | $17.61 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097065779 | CMS |
| Novo Nordisk Inc | $18.04 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096731338 | CMS |
| Seqirus USA Inc | $21.20 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125637023 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.